Abstract
Plants are among the many creatures that have benefited from the widespread application of the CRISPR-associated Cas system as a genome-editing tool for investigating gene function, identifying disease, and enhancing agricultural yields. Although the CRISPR/Cas systems for DNA editing are widely employed, post-transcriptional manipulation of RNA remains difficult despite the prevalence of Cas9. Type VI CRISPR/Cas systems, which were recently found, allow for precise RNA editing without permanently affecting the genome. Cas13d has been put to good use in RNA-related studies across a wide range of RNA knock-down, and RNA detection without affecting DNA. Regulation of cas13d specificity and activity helps to avoid the off-target effects and immune responses in plants. Cas13d as highly efficient RNA-targeting tools for the virus resistance, gene function studies, disease diagnostics, and crop improvement in plants. However, CRISPR/Cas13d applications in plant RNA biology are just getting started. This article discusses how RNA editing tools derived from the CRISPR/Cas13d system are currently being used and where they may be used in the future for plant research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data available on request from the authors.
References
Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis DB, Qi LS (2020) Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell 181(4):865-876.e812. https://doi.org/10.1016/j.cell.2020.04.020
Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A, Lander ES, Voytas DF, Ting AY, Zhang F (2017) RNA targeting with CRISPR-Cas13. Nature 550(7675):280–284. https://doi.org/10.1038/nature24049
Abudayyeh OO, Gootenberg JS, Kellner MJ, Zhang F (2019) Nucleic acid detection of plant genes using CRISPR-Cas13. Crispr j 2(3):165–171. https://doi.org/10.1089/crispr.2019.0011
Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353(6299):aaf5573. https://doi.org/10.1126/science.aaf5573
Aman R, Ali Z, Butt H, Mahas A, Aljedaani F, Khan MZ, Ding S, Mahfouz M (2018) RNA virus interference via CRISPR/Cas13a system in plants. Genome Biol 19(1):1–9
Bandaru S, Tsuji MH, Shimizu Y, Usami K, Lee S, Takei NK, Yoshitome K, Nishimura Y, Otsuki T, Ito T (2020) Structure-based design of gRNA for Cas13. Sci Rep 10(1):11610
Bi D, Yao J, Wang Y, Qin G, Zhang Y, Wang Y, Zhao J (2021) CRISPR/Cas13d-mediated efficient KDM5B mRNA knockdown in porcine somatic cells and parthenogenetic embryos. Reproduction 162(2):149–160. https://doi.org/10.1530/rep-21-0053
Cheng X, Li Z, Shan R, Li Z, Wang S, Zhao W, Zhang H, Chao L, Peng J, Fei T, Li W (2023) Modeling CRISPR–Cas13d on-target and off-target effects using machine learning approaches. Nat Commun 14(1):752. https://doi.org/10.1038/s41467-023-36316-3
Chuang YF, Wang PY, Kumar S, Lama S, Lin FL, Liu GS (2021) Methods for in vitro CRISPR/CasRx-mediated RNA editing. Front Cell Dev Biol 9:667879. https://doi.org/10.3389/fcell.2021.667879
Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F (2017) RNA editing with CRISPR-Cas13. Science 358(6366):1019–1027. https://doi.org/10.1126/science.aaq0180
Das A, Goswami HN, Whyms CT, Sridhara S, Li H (2022) Structural principles of CRISPR-Cas enzymes used in nucleic acid detection. J Struct Biol 214(1):107838. https://doi.org/10.1016/j.jsb.2022.107838
Du M, Jillette N, Zhu JJ, Li S, Cheng AW (2020) CRISPR artificial splicing factors. Nat Commun 11(1):2973. https://doi.org/10.1038/s41467-020-16806-4
East-Seletsky A, O’Connell MR, Knight SC, Burstein D, Cate JHD, Tjian R, Doudna JA (2016) Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature 538(7624):270–273. https://doi.org/10.1038/nature19802
Freije CA, Myhrvold C, Boehm CK, Lin AE, Welch NL, Carter A, Metsky HC, Luo CY, Abudayyeh OO, Gootenberg JS, Yozwiak NL, Zhang F, Sabeti PC (2019) Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell 76(5):826-837.e811. https://doi.org/10.1016/j.molcel.2019.09.013
Garbo S, Maione R, Tripodi M, Battistelli C (2022) Next RNA therapeutics: the mine of non-coding. Int J Mol Sci. https://doi.org/10.3390/ijms23137471
Granados-Riveron JT, Aquino-Jarquin G (2018) CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 78(15):4107–4113. https://doi.org/10.1158/0008-5472.Can-18-0785
Guo X, Rahman JA, Wessels HH, Méndez-Mancilla A, Haro D, Chen X, Sanjana NE (2021) Transcriptome-wide Cas13 guide RNA design for model organisms and viral RNA pathogens. Cell Genom. https://doi.org/10.1016/j.xgen.2021.100001
Gupta R, Ghosh A, Chakravarti R, Singh R, Ravichandiran V, Swarnakar S, Ghosh D (2022a) Cas13d: a new molecular scissor for transcriptome engineering. Front Cell Dev Biol 10:866800. https://doi.org/10.3389/fcell.2022.866800
Gupta R, Ghosh A, Chakravarti R, Singh R, Ravichandiran V, Swarnakar S, Ghosh D (2022b) Cas13d: a new molecular scissor for transcriptome engineering. Front Cell Develop Biol 10:866800
Hajizadeh Dastjerdi A, Newman A, Burgio G (2019) The expanding class 2 CRISPR toolbox: diversity, applicability, and targeting drawbacks. BioDrugs 33(5):503–513. https://doi.org/10.1007/s40259-019-00369-y
He B, Peng W, Huang J, Zhang H, Zhou Y, Yang X, Liu J, Li Z, Xu C, Xue M, Yang H, Huang P (2020) Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver. Protein Cell 11(7):518–524. https://doi.org/10.1007/s13238-020-00700-2
Huynh N, Depner N, Larson R, King-Jones K (2020) A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila. Genome Biol 21(1):279. https://doi.org/10.1186/s13059-020-02193-y
Jackson SA, Fineran PC (2019) Bacterial dormancy curbs phage epidemics. Nature 570(7760):173–174. https://doi.org/10.1038/d41586-019-01595-8
Kavuri NR, Ramasamy M, Qi Y, Mandadi K (2022) Applications of CRISPR/Cas13-based RNA editing in plants. Cells. https://doi.org/10.3390/cells11172665
Kelley CP, Haerle MC, Wang ET (2022) Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR–Cas13d in mammalian cells. Cell Rep 40(7):111226. https://doi.org/10.1016/j.celrep.2022.111226
Kiga K, Tan XE, Ibarra-Chávez R, Watanabe S, Aiba Y et al (2020) Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun 11(1):2934
Knott GJ, East-Seletsky A, Cofsky JC, Holton JM, Charles E, O’Connell MR, Doudna JA (2017) Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme. Nat Struct Mol Biol 24(10):825–833. https://doi.org/10.1038/nsmb.3466
Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD (2018) Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173(3):665-676.e614. https://doi.org/10.1016/j.cell.2018.02.033
Kumar P, Malik YS, Ganesh B, Rahangdale S, Saurabh S, Natesan S, Srivastava A, Sharun K, Yatoo MI, Tiwari R, Singh RK, Dhama K (2020) CRISPR-Cas System: an approach with potentials for COVID-19 diagnosis and therapeutics. Front Cell Infect Microbiol 10:576875. https://doi.org/10.3389/fcimb.2020.576875
Kumlehn J, Pietralla J, Hensel G, Pacher M, Puchta H (2018) The CRISPR/Cas revolution continues: from efficient gene editing for crop breeding to plant synthetic biology. J Integr Plant Biol 60(12):1127–1153
Kushawah G, Hernandez-Huertas L, Abugattas-Nuñez Del Prado J, Martinez-Morales JR, DeVore ML, Hassan H, Moreno-Sanchez I, Tomas-Gallardo L, Diaz-Moscoso A, Monges DE, Guelfo JR, Theune WC, Brannan EO, Wang W, Corbin TJ, Moran AM, Sánchez Alvarado A, Málaga-Trillo E, Takacs CM, Moreno-Mateos MA (2020a) CRISPR–Cas13d induces efficient mRNA knockdown in animal embryos. Dev Cell 54(6):805-817.e807. https://doi.org/10.1016/j.devcel.2020.07.013
Kushawah G, Hernandez-Huertas L, Del Prado JAN, Martinez-Morales JR, DeVore ML, Hassan H, Moreno-Sanchez I, Tomas-Gallardo L, Diaz-Moscoso A, Monges DE (2020b) CRISPR–Cas13d induces efficient mRNA knockdown in animal embryos. Develop Cell 54(6):805-817.e807
Kwon SW, Paari KA, Malaviya A, Jang YS (2020) Synthetic biology tools for genome and transcriptome engineering of solventogenic clostridium. Front Bioeng Biotechnol 8:282. https://doi.org/10.3389/fbioe.2020.00282
Lin M-W, Shen C-C, Lin Y-J, Chou M-Y, Pham NN, Chang Y-H, Chang C-W, Hwu JR, Nguyen MTT, Hu Y-C (2021) Enhancing the yield and activity of defucosylated antibody produced by CHO-K1 cells using Cas13d-mediated multiplex gene targeting. J Taiwan Inst Chem Eng 121:38–47
Liu G, Lin Q, Jin S, Gao C (2022) The CRISPR-Cas toolbox and gene editing technologies. Mol Cell 82(2):333–347. https://doi.org/10.1016/j.molcel.2021.12.002
Liu L, Pei D-S (2022a) Insights gained from RNA editing targeted by the CRISPR-Cas13 family. Int J Mol Sci 23(19):11400
Liu L, Pei DS (2022b) Insights gained from RNA editing targeted by the CRISPR-Cas13 family. Int J Mol Sci. https://doi.org/10.3390/ijms231911400
Lotfi M, Rezaei N (2020) CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother 131:110738. https://doi.org/10.1016/j.biopha.2020.110738
Ma Y-F, Zhang M-Q, Gong L-L, Liu X-Z, Long G-J, Guo H, Hull JJ, Dewer Y, He M, He P (2023) Efficient nanoparticle-based CRISPR–Cas13d induced mRNA disruption of an eye pigmentation gene in the white-backed planthopper, Sogatella furcifera. Insect Sci 30(6):1552–1564. https://doi.org/10.1111/1744-7917.13203
Mahas A, Aman R, Mahfouz M (2019) CRISPR–Cas13d mediates robust RNA virus interference in plants. Genome Biol 20(1):263. https://doi.org/10.1186/s13059-019-1881-2
Marina RJ, Brannan KW, Dong KD, Yee BA, Yeo GW (2020) Evaluation of engineered CRISPR-Cas-mediated systems for site-specific RNA editing. Cell Rep 33(5):108350. https://doi.org/10.1016/j.celrep.2020.108350
Marqués MC, Sánchez-Vicente J, Ruiz R, Montagud-Martínez R, Márquez-Costa R, Gómez G, Carbonell A, Daròs JA, Rodrigo G (2022) Diagnostics of infections produced by the plant viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13. ACS Synth Biol 11(7):2384–2393. https://doi.org/10.1021/acssynbio.2c00090
Meeske AJ, Nakandakari-Higa S, Marraffini LA (2019) Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage. Nature 570(7760):241–245. https://doi.org/10.1038/s41586-019-1257-5
Palaz F, Kalkan AK, Can Ö, Demir AN, Tozluyurt A, Özcan A, Ozsoz M (2021) CRISPR-Cas13 system as a promising and versatile tool for cancer diagnosis, therapy, and research. ACS Synth Biol 10(6):1245–1267. https://doi.org/10.1021/acssynbio.1c00107
Peng Z, Guo HY, Li YQ, Li JC, Yang XH, Liu J, Hu QD, Wang HL, Wang L (2022) The Smad3-dependent microRNA let-7i-5p promoted renal fibrosis in mice with unilateral ureteral obstruction. Front Physiol 13:937878. https://doi.org/10.3389/fphys.2022.937878
Perčulija V, Lin J, Zhang B, Ouyang S (2021a) Functional features and current applications of the RNA-targeting type VI CRISPR-Cas systems. Adv Sci (weinh) 8(13):2004685. https://doi.org/10.1002/advs.202004685
Perčulija V, Lin J, Zhang B, Ouyang S (2021b) Functional features and current applications of the RNA-targeting type VI CRISPR-Cas systems. Adv Sci 8(13):2004685
Qiao X, Gao Y, Li J, Wang Z, Qiao H, Qi H (2021) Sensitive analysis of single nucleotide variation by Cas13d orthologs, EsCas13d and RspCas13d. Biotechnol Bioeng 118(8):3037–3045. https://doi.org/10.1002/bit.27813
Reshetnikov VV, Chirinskaite AV, Sopova JV, Ivanov RA, Leonova EI (2022) Cas-based systems for RNA editing in gene therapy of monogenic diseases: in vitro and in vivo application and translational potential. Front Cell Dev Biol 10:903812. https://doi.org/10.3389/fcell.2022.903812
Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, Zhang F, Koonin EV (2015) Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell 60(3):385–397. https://doi.org/10.1016/j.molcel.2015.10.008
Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI, Severinov K, Zhang F, Koonin EV (2017) Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol 15(3):169–182. https://doi.org/10.1038/nrmicro.2016.184
Smargon AA, Cox DBT, Pyzocha NK, Zheng K, Slaymaker IM, Gootenberg JS, Abudayyeh OA, Essletzbichler P, Shmakov S, Makarova KS, Koonin EV, Zhang F (2017) Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol Cell 65(4):618-630.e617. https://doi.org/10.1016/j.molcel.2016.12.023
Tang T, Han Y, Wang Y, Huang H, Qian P (2021) Programmable system of Cas13-mediated RNA modification and its biological and biomedical applications. Front Cell Develop Biol 9:677587
Treichel AJ, Bazzini AA (2022) Casting CRISPR–Cas13d to fish for microprotein functions in animal development. iScience 25(12):105547. https://doi.org/10.1016/j.isci.2022.105547
Wang F, Wang L, Zou X, Duan S, Li Z, Deng Z, Luo J, Lee SY, Chen S (2019) Advances in CRISPR-Cas systems for RNA targeting, tracking and editing. Biotechnol Adv 37(5):708–729. https://doi.org/10.1016/j.biotechadv.2019.03.016
Wei J, Lotfy P, Faizi K, Baungaard S, Gibson E, Wang E, Slabodkin H, Kinnaman E, Chandrasekaran S, Kitano H (2021) Deep learning and CRISPR–Cas13d ortholog discovery for optimized RNA targeting. bioRxiv 353:6299
Wessels HH, Méndez-Mancilla A, Guo X, Legut M, Daniloski Z, Sanjana NE (2020) Massively parallel Cas13 screens reveal principles for guide RNA design. Nat Biotechnol 38(6):722–727. https://doi.org/10.1038/s41587-020-0456-9
Wu QW, Kapfhammer JP (2021) The Bacterial enzyme RfxCas13d is less neurotoxic than PspCas13b and could be a promising RNA editing and interference tool in the nervous system. Brain Sci. https://doi.org/10.3390/brainsci11081054
Xia Z, Tang M, Ma J, Zhang H, Gimple RC, Prager BC, Tang H, Sun C, Liu F, Lin P, Mei Y, Du R, Rich JN, Xie Q (2021) Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase. Nucleic Acids Res 49(13):7361–7374. https://doi.org/10.1093/nar/gkab517
Yan WX, Chong S, Zhang H, Makarova KS, Koonin EV, Cheng DR, Scott DA (2018) Cas13d Is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol Cell 70(2):327-339.e325. https://doi.org/10.1016/j.molcel.2018.02.028
Yan WX, Hunnewell P, Alfonse LE, Carte JM, Keston-Smith E, Sothiselvam S, Garrity AJ, Chong S, Makarova KS, Koonin EV, Cheng DR, Scott DA (2019) Functionally diverse type V CRISPR-Cas systems. Science 363(6422):88–91. https://doi.org/10.1126/science.aav7271
Yang F (2022) Promoter antisense RNAs: beyond transcription by-products of active promoters. RNA Biol 19(1):533–540. https://doi.org/10.1080/15476286.2022.2062177
Yu Y, Pan Z, Wang X, Bian X, Wang W, Liang Q, Kou M, Ji H, Li Y, Ma D, Li Z, Sun J (2022) Targeting of SPCSV-RNase3 via CRISPR-Cas13 confers resistance against sweet potato virus disease. Mol Plant Pathol 23(1):104–117. https://doi.org/10.1111/mpp.13146
Zhan X, Liu W, Nie B, Zhang F, Zhang J (2023) Cas13d-mediated multiplex RNA targeting confers a broad-spectrum resistance against RNA viruses in potato. Commun Biol 6(1):855. https://doi.org/10.1038/s42003-023-05205-2
Zhan X, Zhang F, Zhong Z, Chen R, Wang Y, Chang L, Bock R, Nie B, Zhang J (2019) Generation of virus-resistant potato plants by RNA genome targeting. Plant Biotechnol J 17(9):1814–1822. https://doi.org/10.1111/pbi.13102
Zhang B, Ye Y, Ye W, Perčulija V, Jiang H, Chen Y, Li Y, Chen J, Lin J, Wang S, Chen Q, Han YS, Ouyang S (2019a) Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d. Nat Commun 10(1):2544. https://doi.org/10.1038/s41467-019-10507-3
Zhang C, Konermann S, Brideau NJ, Lotfy P, Wu X, Novick SJ, Strutzenberg T, Griffin PR, Hsu PD, Lyumkis D (2018) Structural basis for the RNA-guided ribonuclease activity of CRISPR–Cas13d. Cell 175(1):212-223.e217. https://doi.org/10.1016/j.cell.2018.09.001
Zhang H, Dong C, Li L, Wasney GA, Min J (2019b) Structural insights into the modulatory role of the accessory protein WYL1 in the Type VI-D CRISPR-Cas system. Nucleic Acids Res 47(10):5420–5428. https://doi.org/10.1093/nar/gkz269
Zhang J, You Y (2020). CRISPR-Cas13a system: a novel approach to precision oncology. Cancer Biol Med 17(1):6–8. https://doi.org/10.20892/j.issn.2095-3941.2019.0325
Zhang K, Zhang Z, Kang J, Chen J, Liu J, Gao N, Fan L, Zheng P, Wang Y, Sun J (2020a) CRISPR/Cas13d-Mediated Microbial RNA Knockdown. Front Bioeng Biotechnol 8:856. https://doi.org/10.3389/fbioe.2020.00856
Zhang N, Bewick B, Xia G, Furling D, Ashizawa T (2020b) A CRISPR-Cas13a based strategy that tracks and degrades toxic RNA in myotonic dystrophy type 1. Front Genet 11:594576. https://doi.org/10.3389/fgene.2020.594576
Zhang T, Zhao Y, Ye J, Cao X, Xu C, Chen B, An H, Jiao Y, Zhang F, Yang X, Zhou G (2019c) Establishing CRISPR/Cas13a immune system conferring RNA virus resistance in both dicot and monocot plants. Plant Biotechnol J 17(7):1185–1187. https://doi.org/10.1111/pbi.13095
Zhang Y, Nguyen TM, Zhang X-O, Wang L, Phan T, Clohessy JG, Pandolfi PP (2021a) Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome Biol 22:1–22
Zhang Y, Nguyen TM, Zhang XO, Wang L, Phan T, Clohessy JG, Pandolfi PP (2021b) Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome Biol 22(1):41. https://doi.org/10.1186/s13059-021-02263-9
Zhang Y, Pribil M, Palmgren M, Gao C (2020c) A CRISPR way for accelerating improvement of food crops. Nature Food 1(4):200–205
Zhang YY, Sun MX, Lian Y, Wang TY, Jia MY, Leng C, Chen M, Bai YZ, Meng F, Cai XH, Tang YD (2022) CRISPR–Cas13d exhibits robust antiviral activity against seneca valley virus. Front Microbiol 13:835040. https://doi.org/10.3389/fmicb.2022.835040
Acknowledgements
The authors would like to acknowledge ISF College of Pharmacy provides the software and helpful advice and support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors did not have any conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sarkar, J., Jyoti, T.P., Sahana, S. et al. CRISPR–Cas13d in plant biology: an insight. Plant Biotechnol Rep (2024). https://doi.org/10.1007/s11816-024-00893-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11816-024-00893-6